Active Pharmaceutical Ingredients Market Report

Visiongain has published a new report on Active Pharmaceutical Ingredients Market Report to 2031: API forecast (Branded / Innovative and Generic), by type of synthesis (Synthetic and Biotech), by application (diabetes, oncology, cardiovascular, central nervous system, analgesics and others) PLUS COVID-19 recovery scenarios.

Impact of COVID-19 on the market for active pharmaceutical ingredients

The COVID-19 pandemic has posed an unprecedented health risk. Small start-ups, biopharmaceuticals and pharmaceuticals have taken initiatives to develop treatments against target infections linked to Covid 19. Researchers have found a number of molecules capable of fighting the deadliest virus. Currently, around 155 molecules are in clinical research and around 45 molecules are in preclinical testing. To this end, several molecules have been reused such as Remdesivir, Lopinavir & Ritonavir, Chloroquine & Hydroxychloroquine, and Lopinavir with Ritonavir plus Interferon beta-1a. In March 2020, the World Health Organization (WHO) announced that the organization had started a global mega-trial of the four most promising drugs against SARS-CoV-2. Countries are in a global rivalry to develop and manufacture an effective treatment for SARS-CoV-2. It has led to an increase in funding and the search for therapeutic molecules that will lead to the demand for active pharmaceutical ingredients lately.

Download an exclusive sample report @

Market factors

Growing prevalence of chronic disease
The increasing incidence and prevalence of cardiovascular disease, osteoarthritis and multiple cancers is expected to be the major growth factors of the active pharmaceutical ingredients market during the forecast period. According to estimates from Cancer Australia, around 1,405 new cases of brain cancer are expected in 2017. In addition, according to the World Health Organization (WHO), the common cause of death is cardiovascular disease (CVD) in the world. In addition, according to the Centers for Disease Control and Prevention (CDC), nearly 1.70 million people die of chronic disease each year in the United States.

Although chronic disease is the leading cause of death for both men and women, as women face unique health issues. About 37% of women suffer from chronic diseases, compared to 30% of men. In addition, according to estimates by the World Health Organization (WHO), by 2050, around 130 million people are expected to suffer from osteoarthritis worldwide. Thus, the increasing high prevalence of cardiovascular disease and other chronic disorders requires appropriate management of treatment to maximize patient outcomes. In turn, it is expected to achieve substantial levels growth of active pharmaceutical ingredients market within the allotted time.

Availability of research funding
Increasing research and development activities and funding from government and many public-private organizations in the development of new drugs ultimately contribute to the growth of the active pharmaceutical ingredients market. Growing government initiatives in emerging economies, the existence of a large number of pharmaceutical pipelines and their therapeutic applications are the crucial factors fueling the demand for active pharmaceutical ingredients, thus contributing to the growth of the target industry.

Market opportunities

Emerging market for biosimilars

The increasing prevalence of acute and chronic diseases such as rheumatoid arthritis and blood disorders, the growing number of non-proprietary and non-patented biologic drugs, the positive results of ongoing clinical trials for biosimilars and the growing demand for biosimilars in various indications clinics are propelling the growth of the global biosimilars market.

Biosimilars are a generic form of patented biologic drugs, so they do not need to meet the strict needs of many regulatory authorities, making them cost effective compared to patented biologics. The expiration of intellectual property rights of original organic products in the coming years is expected to create opportunities for the biosimilar market.

Get the detailed table of contents @

How the Active Pharmaceutical Ingredients Market Report Helps You
In summary, our 500+ page report provides you with the following insights:

  • Revenue forecast to 2031 for Active pharmaceutical ingredients Market, with forecast for API, synthesis type, and application, each forecast globally and regionally – learn about the outlook for the industry, finding the most lucrative locations for investment and revenue
  • Revenue forecast to 2031 for 5 regional markets and 16 key national markets – See forecast for the active pharmaceutical ingredients market in North America, Europe, Asia-Pacific and the rest of the world. The market is also expected in the United States, Canada, Argentina, Brazil, Germany, France, United Kingdom, Italy, Spain, China, India, Japan and Australia among others. significant savings.
  • Outlook for established companies and those looking to enter the market, including company profiles of 10 of the leading companies involved in the active pharmaceutical ingredients market.

Competitive landscape

The main players operating in the Global Active Pharmaceutical Ingredients Market are AbbVie Inc., Mylan NV, Cipla Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Bristol-Myers Squibb Company, Aurobindo Pharma, Albemarle Corporation and Laboratories Dr Reddy’s Ltd.

You will find quantitative and qualitative analyzes with independent predictions. You will receive information that only our report contains, staying informed thanks to this valuable business intelligence.

To access the data contained in this document, please send an email [email protected]

Information found nowhere else
With our survey, you are less likely to fall behind in your knowledge or miss an opportunity. See how you could benefit from your research, analysis and decisions. Also find out how you can save time and be recognized for your business knowledge.

The Visiongain study is aimed at anyone needing business analysis for the Active pharmaceutical ingredients market and leading companies. Here you will find data, trends and forecasts. Please order our report now.

Find more Visiongain research reports at Therapeutic drugs sector click on the following links:

Do you have custom requirements that we can help you with? Do you need specific information about a specific country, geographic region, market segment or company? Contact us today, we can discuss your needs and see how we can help you: [email protected]

About Visiongain

Visiongain is one of the fastest growing and most innovative independent market information, the company publishes hundreds of market research reports which she adds each year to her vast portfolio. These reports provide in-depth analysis of 18 industries around the world. The reports cover a 10-year forecast, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works in a range of vertical markets, which can currently influence each other, these markets include the automotive, aviation, chemicals, cybersecurity, defense, energy, food and beverage, materials, packaging, pharmacy and utilities. Our customized and syndicated market research reports mean you can have tailor-made market information tailored to your business needs.


Sara peerun
Commercial director
Visiongain Inc.
Phone : + 44 207 549 9987
United States Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
E-mail: [email protected]
The Web:
Follow us: LinkedIn | Twitter

SOURCE Visiongain Limited.

About Margie Peters

Check Also

New Covid-19 vaccines continue to be developed by biotech companies looking to improve the Jab

VANCOUVER, BC, October 6, 2021 / PRNewswire / – United States News Group – As …

Leave a Reply

Your email address will not be published. Required fields are marked *